Margin operasi Haemonetics Corp. (HAE)

Logo perusahaan publik Haemonetics (HAE)

Haemonetics Corporation maintains its leadership in the plasma collection segment via the NexSys system, demonstrating stable growth regardless of market cycles. The current operating margin reflects financial maturity, with 18.50 becoming the new value for this metric. Business development relies on partnerships with clinics to automate blood collection processes to enhance patient safety.

Haemonetics Corp (HAE): Rentabilitas operasi saka 04.07.2022 nganti 19.11.2026

Rincian metrik lan analitis perusahaan haemonetics.com (HAE)

- rega saham lan konsensus proyeksi valuasi:
Analisis kabeh metrik perusahaan:Haemonetics Corp
Produk dadi Haemonetics Corporation

To distinguish a sustainable business from speculative plays, capital analyzes the operating margin, which measures the share of profit from core operations before taxes and interest. By analyzing operating profitability on GURU.Markets, an investor can see how Haemonetics Corporation (HAE) leverages its leadership in hematology and surgeons' trust in system safety to drive real cost-management efficiency and fundamental stability.

Pesaing utama

DXCM (Dexcom CGM) - Margin operasi|Margin dodolan operasi Penumbra Corp (PEN)|Margin operasi NOVT|Margin dodolan operasi Inspire Medical Systems INSP|Margin operasi PRCT (procept-biorobotics.com)|Margin operasi CONMED Corp CNMD|PLSE - Rentabilitas operasi|INMD: Rentabilitas operasi|PMI: Margin operasi|Surmodics, Inc. - Tingkat bathi operasi|SENS (Senseonics Holdings Inc) - Margin operasi|Rentabilitas dodolan operasi NeuroPace Inc NPCE|Rentabilitas operasi Tactile Medical (TCMD)|Sanuwave Health Inc (SNWV) - Tingkat bathi adhedhasar bathi operasi|Rentabilitas operasi Outset OM|Margin operasi Electromed Inc ELMD|LENSAR Inc. - Margin operasi|Rentabilitas kegiatan operasi AVITA Medical Inc. RCEL|Profound Medical (PROF) - Rentabilitas operasi|Margin bathi operasi BDMD (Baird Medical Corp)|Rentabilitas operasi edap-tms.com|Margin dodolan operasi Apyx Medical (APYX)|Margin operasi ICCM|LUNG - Rentabilitas dodolan operasi|Rentabilitas operasi telabio.com TELA|CTSO: Rentabilitas dodolan miturut bathi operasi|SRTS: Margin dodolan operasi|Zynex - Rasio bathi operasi|ECOR: Margin operasi|RBOT (Vicarious Surgical Inc) - Rentabilitas operasi|Rentabilitas operasi Inspira Technologies|Margin operasi SeaStar Medical Holding Corp.|Margin operasi IRIX|Rasio bathi operasi INBS|Rentabilitas operasi Beyond Air XAIR|PFSA (Profusa, Inc.) - Margin bathi operasi|SSKN: Margin dodolan operasi|Rentabilitas dodolan operasi GlucoTrack|NAOV: Margin operasi|Venus Concept Inc. - Tingkat bathi operasi|NUWE (Nuwellis Inc) - Margin operasi|Rentabilitas dodolan miturut bathi operasi AEMD (Aethlon)|Margin dodolan operasi ASXC (Asensus Surgical Inc)|AVGR (Avinger, Inc) - Tingkat bathi operasi|Margin operasi BSGM (BioSig Technologies, Inc.)|CUTR: Rentabilitas dodolan miturut bathi operasi|Know Labs Inc - Margin operasi|Rentabilitas kegiatan operasi Inari Medical NARI|NVRO (Nevro Medical) - Margin dodolan operasi|Margin bathi operasi RSLS (ReShape Lifesciences, Inc.)|SILK (Silk Road Medical, Inc.) - Margin operasi